Home › Funds › Arrowstreet Capital › ALKS
Arrowstreet Capital position in ALKS
ALKERMES PLC · Health Care
Latest position (Q4 2025)1.45M sh
Reported value held$40.59M
Portfolio Weight0.02%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 2.15M | $56.49M | New |
| Q2 2022 | 650.22K | $19.37M | Reduce |
| Q3 2022 | 887.74K | $19.82M | Add |
| Q4 2022 | 1.25M | $32.73K | Add |
| Q1 2023 | 677.93K | $19.11K | Reduce |
| Q2 2023 | 756.40K | $23.68K | Add |
| Q3 2023 | 995.23K | $27.88K | Add |
| Q4 2023 | 163.51K | $4.54K | Reduce |
| Q1 2024 | 134.18K | $3.63K | Reduce |
| Q2 2025 | 103.28K | $2.95M | New |
| Q3 2025 | 1.21M | $36.27M | Add |
| Q4 2025 | 1.45M | $40.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALKS
- BlackRock Inc 29.24M sh · $1.53B · Q2 2026
- Vanguard Group 18.01M sh · $503.85M · Q4 2025
- Renaissance Technologies 6.46M sh · $338.52M · Q2 2026
- Geode Capital Management 4.48M sh · $234.66M · Q2 2026
- Wellington Management Group 2.81M sh · $147.48M · Q2 2026
- Charles Schwab Investment Management 2.34M sh · $122.35M · Q2 2026
- Norges Bank Investment Management 2.16M sh · $113.01M · Q2 2026
- Goldman Sachs Group 2.02M sh · $106.05M · Q2 2026
- Citadel Advisors 1.89M sh · $99.13M · Q2 2026
- Northern Trust Corp 1.83M sh · $95.97M · Q2 2026
- Morgan Stanley 1.75M sh · $91.79M · Q2 2026
- D. E. Shaw & Co 1.31M sh · $68.74M · Q2 2026